Synovus Financial’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,122
| Closed | -$217K | – | 859 |
|
|
2024
Q1 | $217K | Buy |
6,122
+467
| +8% | +$16.6K | ﹤0.01% | 799 |
|
|
2023
Q4 | $246K | Sell |
5,655
-44
| -0.8% | -$1.92K | ﹤0.01% | 759 |
|
|
2023
Q3 | $218K | Buy |
5,699
+26
| +0.5% | +$993 | ﹤0.01% | 783 |
|
|
2023
Q2 | $233K | Sell |
5,673
-232
| -4% | -$9.54K | ﹤0.01% | 780 |
|
|
2023
Q1 | $339K | Sell |
5,905
-915
| -13% | -$52.5K | ﹤0.01% | 695 |
|
|
2022
Q4 | $382K | Buy |
6,820
+217
| +3% | +$12.2K | ﹤0.01% | 683 |
|
|
2022
Q3 | $283K | Sell |
6,603
-491
| -7% | -$21K | ﹤0.01% | 721 |
|
|
2022
Q2 | $376K | Buy |
7,094
+152
| +2% | +$8.06K | ﹤0.01% | 658 |
|
|
2022
Q1 | $449K | Buy |
6,942
+4
| +0.1% | +$259 | ﹤0.01% | 649 |
|
|
2021
Q4 | $457K | Buy |
6,938
+112
| +2% | +$7.38K | ﹤0.01% | 659 |
|
|
2021
Q3 | $466K | Sell |
6,826
-3,087
| -31% | -$211K | ﹤0.01% | 622 |
|
|
2021
Q2 | $678K | Buy |
9,913
+105
| +1% | +$7.18K | 0.01% | 536 |
|
|
2021
Q1 | $677K | Buy |
9,808
+158
| +2% | +$10.9K | 0.01% | 485 |
|
|
2020
Q4 | $628K | Buy |
9,650
+845
| +10% | +$55K | 0.01% | 495 |
|
|
2020
Q3 | $417K | Buy |
8,805
+288
| +3% | +$13.6K | 0.01% | 534 |
|
|
2020
Q2 | $400K | Buy |
8,517
+16
| +0.2% | +$751 | 0.01% | 514 |
|
|
2020
Q1 | $377K | Buy |
8,501
+454
| +6% | +$20.1K | 0.01% | 599 |
|
|
2019
Q4 | $473K | Sell |
8,047
-1,125
| -12% | -$66.1K | 0.01% | 482 |
|
|
2019
Q3 | $553K | Buy |
+9,172
| New | +$553K | 0.01% | 436 |
|